Topics:

Osteoporosis

On Stopping Bisphosphonates: When and How?

How serious is the risk of atypical femur fracture for osteoporosis patients on bisphosphonates, and when is a "drug holiday" justified? There are no definitive studies or guidelines, but here are some strategies to consider.

Osteoporosis

In this video, Steven R. Goldstein, MD, professor of obstetrics and gynecology at NYU, discusses new research he presented in October at the 25th annual North American Menopause Society meeting.

New data boosts confidence in drug therapies for osteoporosis, but more research in older adults is required.

A review article in the Medical Letter highlights appropriate use and limitations of bisphosphonates, denosumab, and other osteoporosis treatment, along with the associated costs.

Menopause will be unique for each woman, and a physician-patient partnership is a must if women want effective menopause management.

Osteoporosis isn't a disease of older women; it's a disease of all women, incubating in even our youngest patients.

Look no further: The North American Menopause Society has issued recommendations that offer the latest information for managing a woman's health through menopause.

A quiz in JAMA uses a case with discordant DXA results to discuss the options in assessment of hip fracture risk in osteoporosis, describing their advantages and drawbacks.

Pages

Subscribe to Osteoporosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.